Reducing regulatory risk with CMC strategy using gene therapy platforms
Conference Dates
February 4 - 8, 2024
Abstract
Please click Additional Files below to see the full abstract.
Recommended Citation
Doris Snow, "Reducing regulatory risk with CMC strategy using gene therapy platforms" in "Advancing Manufacture of Cell and Gene Therapies VIII", Fernanda Masri, Cytomos, United Kingdom; Carolyn Yeago, CY Solutions LLC, USA; Gargi Maheshwari, BMS, USA; John Moscariello, BMS, USA Eds, ECI Symposium Series, (2024). https://dc.engconfintl.org/cell_gene_therapies_viii/63
Keynote - Kimberly Benton.pdf (85 kB)
COinS